News and Media
News Updates
Intelligent Bio Solutions to Participate in the LD Micro Invitational XIII on June 6th
Intelligent Bio Solutions has announced that management will be participating in the LD Micro Invitational XIII in Los Angeles, June
Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution
Lab-testing pathway to expand capabilities of proprietary drug test screening to detect potent opioid fentanyl and fentanyl-adulterated street drugs.
INTELLIGENT BIO SOLUTIONS INC. REPORTS FISCAL 2023 THIRD QUARTER FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
Intelligent Bio Solutions Inc. today announced its financial results for its fiscal third quarter ended March 31, 2023, and provided
Intelligent Bio Solutions Scales Reach Throughout Asia-Pacific Region with Addition of Sales Team in Australia, New Distribution Hub and Office Facility
Intelligent Bio Solutions Inc. announces the recruitment of four highly experienced sales executives from across the workplace safety and supply,
UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions’ Portable Fingerprint Drug Testing Solution
Dodman Limited, specialists in the design, manufacture, installation and maintenance of processing systems for major food manufacturers, has selected our
Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader
Intelligent Bio Solutions has been granted a patent in the United Kingdom (UK) relating to its Intelligent Fingerprinting Drug Screening
A&F Sprinklers Selects Intelligent Bio Solutions’ Latest DSR-Plus Screening Unit to Support its Random Drug Screening Program
A & F Sprinklers, one of the UK’s leading fire protection and automatic sprinkler systems specialists, has selected Intelligent Bio
Intelligent Bio Solutions Selects HASTA Laboratory as Drug Testing Specialist in Australia
Intelligent Bio Solutions has selected Human and Supplement Testing Australia (“HASTA”), Australia’s largest independent sports drug testing laboratory, as its
Intelligent Bio Solutions Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
Intelligent Bio Solutions today announced the closing of its previously announced underwritten public offering. Ladenburg Thalmann & Co. Inc. acted
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering NEW YORK, NY, March 8, 2023 — Intelligent Bio
Intelligent Bio Solutions Inc. Announces Proposed Public Offering
Intelligent Bio Solutions Inc. Announces Proposed Public Offering NEW YORK, NY, March 07, 2023 — Intelligent Bio Solutions Inc. (“Intelligent
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement NEW YORK, NY, March 1, 2023 — Intelligent Bio Solutions
Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge
Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge – 513(g) submission will allow
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights – Second quarter total revenue and
Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing
Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing Boughey Distribution
Media
